
Choice of anticoagulant in patients with atrial fibrillation that occurred in the conditions of COVID-19 (clinical case)
Author(s) -
E. P. Panchenko
Publication year - 2022
Publication title -
aterotromboz
Language(s) - English
Resource type - Journals
eISSN - 2658-5952
pISSN - 2307-1109
DOI - 10.21518/2307-1109-2022-12-1-84-112
Subject(s) - atrial fibrillation , medicine , dabigatran , catheter ablation , perioperative , cardiology , management of atrial fibrillation , covid-19 , anesthesia , anticoagulant , stroke (engine) , warfarin , rivaroxaban , intensive care medicine , disease , mechanical engineering , infectious disease (medical specialty) , engineering